Profiles of mi RNA s in serum in severe acute drug induced liver injury and their prognostic significance-Reference-Cited by-同舟云学术

Profiles of mi RNA s in serum in severe acute drug induced liver injury and their prognostic significance

Published:2016-11-29 Issue:5 Volume:37 Page:757-764
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Russo Mark W.¹,Steuerwald Nury¹,Norton Harry J.¹,Anderson William E.¹,Foureau David¹,Chalasani Naga²,Fontana Robert J.³,Watkins Paul B.⁴,Serrano Jose⁵,Bonkovsky Herbert L.⁶

Affiliation:

1. Carolinas Healthcare System Charlotte NC USA

2. Indiana University School of Medicine Indianapolis IN USA

3. University of Michigan School of Medicine Ann Arbor MI USA

4. University of North Carolina School of Medicine Chapel Hill NC USA

5. NIDDK Bethesda MD USA

6. Wake Forest University School of Medicine Winston‐Salem NC USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.13312

Reference34 articles.

1. Drug-Induced Liver Injury: Morbidity, Mortality, and Hy’s Law

2. Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study

3. Drug-Induced Liver Injury

4. Drug-Induced Liver Injury Network (DILIN) Prospective Study

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Levels of miR-122-5p and miR-125a-5p Predict Hepatotoxicity Occurrence in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation;International Journal of Molecular Sciences;2024-04-15

2. The challenges and potential of microRNA-based therapy for patients with liver failure syndromes and hepatocellular carcinoma;Expert Opinion on Therapeutic Targets;2024-03-03

3. Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review;Exploration of Digestive Diseases;2023-12-27

4. The challenges and potential in developing microRNA associated with regeneration as biomarkers to improve prognostication for liver failure syndromes and hepatocellular carcinoma;Expert Review of Molecular Diagnostics;2023-12-07

5. Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case–control study;Diagnostic and Prognostic Research;2023-09-12